Going Green: The Role of the Green Tea Component EGCG in Chemoprevention
- PMID: 24077764
- PMCID: PMC3783360
- DOI: 10.4172/2157-2518.1000142
Going Green: The Role of the Green Tea Component EGCG in Chemoprevention
Abstract
Tea is one of the most consumed beverages worldwide, and green tea is the least processed from the buds of the Camellia sinensis plant. The most abundant component of green tea is (-)-epigallocatechin-3-gallate (EGCG), which has been the focus of many cell culture, animal and clinical trials, revealing that EGCG possesses antiproliferative, antimutagenic, antioxidant, antibacterial, antiviral and chemopreventive effects. In this review we briefly summarize the mechanism of action(s) of the green tea component EGCG, highlighting recent advances in the epigenetic regulation by EGCG. Additionally, we provide an overview of mouse chemoprevention studies and EGCG chemoprevention clinical trials.
Keywords: Cancer; Chemoprevention; EGCG; Green tea.
Figures
References
-
- Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 1997;37:693–704. - PubMed
-
- Reto M, Figueira ME, Filipe HM, Almeida CM. Chemical composition of green tea (Camellia sinensis) infusions commercialized in Portugal. Plant Foods Hum Nutr. 2007;62:139–144. - PubMed
-
- Crespy V, Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr. 2004;134:3431S–3440S. - PubMed
-
- Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea: part II. review of anticancer properties. J Altern Complement Med. 2005;11:639–652. - PubMed
-
- Cooper R, Morré DJ, Morré DM. Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J Altern Complement Med. 2005;11:521–528. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources